ES8205353A1 - Un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en formade pastillas que contienen aci-dos acetilsalicilico. - Google Patents

Un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en formade pastillas que contienen aci-dos acetilsalicilico.

Info

Publication number
ES8205353A1
ES8205353A1 ES498369A ES498369A ES8205353A1 ES 8205353 A1 ES8205353 A1 ES 8205353A1 ES 498369 A ES498369 A ES 498369A ES 498369 A ES498369 A ES 498369A ES 8205353 A1 ES8205353 A1 ES 8205353A1
Authority
ES
Spain
Prior art keywords
delayed
manufacturing
acetilsalicilico
per
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES498369A
Other languages
English (en)
Spanish (es)
Other versions
ES498369A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453 external-priority patent/US4308251A/en
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of ES498369A0 publication Critical patent/ES498369A0/es
Publication of ES8205353A1 publication Critical patent/ES8205353A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES498369A 1980-01-11 1981-01-08 Un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en formade pastillas que contienen aci-dos acetilsalicilico. Expired ES8205353A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11143080A 1980-01-11 1980-01-11
US06/194,453 US4308251A (en) 1980-01-11 1980-10-17 Controlled release formulations of orally-active medicaments

Publications (2)

Publication Number Publication Date
ES498369A0 ES498369A0 (es) 1982-06-01
ES8205353A1 true ES8205353A1 (es) 1982-06-01

Family

ID=26808896

Family Applications (2)

Application Number Title Priority Date Filing Date
ES498369A Expired ES8205353A1 (es) 1980-01-11 1981-01-08 Un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en formade pastillas que contienen aci-dos acetilsalicilico.
ES509179A Granted ES509179A0 (es) 1980-01-11 1982-01-29 "un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en forma de pastillas que contiene como agente terapeutico ibuprofen o flurbiprofen".

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES509179A Granted ES509179A0 (es) 1980-01-11 1982-01-29 "un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en forma de pastillas que contiene como agente terapeutico ibuprofen o flurbiprofen".

Country Status (22)

Country Link
JP (1) JPS56103110A (https=)
AT (1) AT374681B (https=)
AU (1) AU542824B2 (https=)
BE (1) BE886998A (https=)
CA (1) CA1140466A (https=)
CH (1) CH646604A5 (https=)
DE (1) DE3100191A1 (https=)
DK (1) DK6181A (https=)
ES (2) ES8205353A1 (https=)
FI (1) FI76927C (https=)
FR (1) FR2473308B1 (https=)
GB (1) GB2067072B (https=)
GR (1) GR73843B (https=)
IE (1) IE50806B1 (https=)
IN (1) IN151913B (https=)
IT (1) IT1221041B (https=)
LU (1) LU83052A1 (https=)
NL (1) NL8100037A (https=)
NO (1) NO156153C (https=)
NZ (1) NZ195933A (https=)
SE (1) SE447450B (https=)
ZA (1) ZA81136B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496082A (en) * 1947-05-24 1950-01-31 Ashenfelter William Scaffold structure
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPH0662404B2 (ja) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
EP0138216B1 (en) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Sustained-release ifn preparation for parenteral administration
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
DE3688188T2 (de) * 1985-12-27 1993-10-14 Koken Kk Verfahren zur Herstellung einer Formulierung mit verzögerter Freisetzung.
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
CA1316110C (en) * 1987-02-27 1993-04-13 Eli Lilly And Company Sustained release matrix formulations
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
US5855915A (en) * 1995-06-30 1999-01-05 Baylor University Tablets or biologically acceptable implants for long-term antiinflammatory drug release

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
NL128902C (https=) * 1960-06-06
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) * 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule

Also Published As

Publication number Publication date
SE8100104L (sv) 1981-07-12
SE447450B (sv) 1986-11-17
AU542824B2 (en) 1985-03-14
DE3100191C2 (https=) 1988-09-01
IE50806B1 (en) 1986-07-23
IT8147537A0 (it) 1981-01-09
LU83052A1 (fr) 1982-09-10
GB2067072A (en) 1981-07-22
ES498369A0 (es) 1982-06-01
ES8301629A1 (es) 1982-12-16
CA1140466A (en) 1983-02-01
FI76927B (fi) 1988-09-30
FI76927C (fi) 1989-01-10
DE3100191A1 (de) 1981-12-10
AU6597681A (en) 1981-07-16
NZ195933A (en) 1982-11-23
AT374681B (de) 1984-05-25
FR2473308B1 (fr) 1985-07-19
NO156153B (no) 1987-04-27
IN151913B (https=) 1983-09-03
ZA81136B (en) 1982-01-27
NL8100037A (nl) 1981-08-03
FI810056L (fi) 1981-07-12
JPS56103110A (en) 1981-08-18
IT1221041B (it) 1990-06-21
ES509179A0 (es) 1982-12-16
NO156153C (no) 1987-08-05
GR73843B (https=) 1984-05-07
NO810062L (no) 1981-07-13
FR2473308A1 (fr) 1981-07-17
CH646604A5 (fr) 1984-12-14
DK6181A (da) 1981-07-12
GB2067072B (en) 1983-08-10
ATA5481A (de) 1983-10-15
BE886998A (fr) 1981-07-08
IE810036L (en) 1981-07-11

Similar Documents

Publication Publication Date Title
ES8205353A1 (es) Un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en formade pastillas que contienen aci-dos acetilsalicilico.
SE8303531D0 (sv) Farmaceutisk komposition
ES264040A1 (es) Un metodo de fabricaciën de pastillas o granulos para administrar a rumiantes sustancias biolëgicamente activas
GB1359614A (en) Method for the manufacture of effervescent tablets
ES489967A1 (es) Procedimiento mejorado para la fabricacion de granulos de pancreatina
GT198303076A (es) Formulaciones de pastillas de accion prolongada con disolucion paulatina.
JPS5581878A (en) Novel derivative of 33quinolinecarboxylic acid* its manufacture* its use as drug and pharmaceutic composition containing said derivative
AR202629A1 (es) Ester del acido ciclopropanocarboxilico, proceso para su preparacion y composiciones insecticidas que lo contienen
ZA792283B (en) Structural analogs of natural glycerides,process for their preparation and pharmaceutical compositions thereof
ATE110267T1 (de) Verfahren zur hestellung von tabletten, die sprühgetrocknetes naproxen oder naproxen natriumsalz enthalten.
IL54859A (en) Derivatives of amidinopenicillanic acid,their production and pharmaceutical compositions containing them
DE3274185D1 (en) Medicinal preparations for glycoside-hydrolase inhibitors
GB1296944A (https=)
JPS5566507A (en) Preparation of foamed tablet
ES8503511A1 (es) Medicamento que contiene muzolimina
JPS5712954A (en) Preparation of solid lemon pop candy having increased refreshing
BR0012939A (pt) Tablete de uma composição particulada compactada, e, processos para produzir grânulos, e para produzir um tablete
IL56003A0 (en) Novel thiol esters of monic acid, their preparation and pharmaceutical compositions containing them
IL38290A0 (en) Derivatives of thienyl fatty acids,their production and pharmaceutical compositions containing them
IT7948907A0 (it) Derivati di 1,3 benzodiossina procedimento per la loro produzione e composizioni farmaceutiche che licontengono come ingredienti attivi
IT7849218A0 (it) Derivati del pregn 4-ene procedimento per la loro produzione e composizioni farmaceutiche che licontengono come ingredienti attivi
SU715548A1 (ru) Шихта дл изготовлени строительных материалов
IT1059698B (it) Derivati dell'acido ciclopropancar bossilico,procedimento per la loro produzione e composizioni insetticide contenenti detti derivati come sostanze attive
IT968018B (it) Esteri dell acido 2 4 diosso 1 3 benzossazin tion fosfonico proce dimento per la loro preparazione e loro impiego come insetticidi e come acaricidi
IL36611A (en) 4-phenoxybutynyl esters of tetramethyl-cyclopropane-carboxylic acid,their manufacture and insecticidal compositions containing them

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990201